Overview
- Editors:
-
-
Franco Muggia
-
NYU Langone Medical Center, New York, USA
-
Alessandro D. Santin
-
Division of Gynecologic Oncology, Yale University, Yale School of Medicine, New Haven, USA
-
Esther Oliva
-
Department of Pathology, Massachusetts General Hospital, Boston, USA
Harvard Medical School, Boston, USA
- Focuses on uterine and endometrial cancers and the impact oncologists can have on the outcome of women diagnosed with these malignancies
- Updated with new chapters on molecular classification of endometrial cancers and hormonal therapies
- Enhances the awareness of this somewhat neglected area of therapeutics
- Helps integrate targeted therapies into the management of women with uterine cancer
- Written by experts in the field in a highly practical and comprehensive manner
- Must-have for all gynecological residents and fellows, gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors
Access this book
Other ways to access
Table of contents (18 chapters)
-
-
- Malcolm C. Pike, Karine Chung, Sara Olson, Celeste L. Pearce, Anna H. Wu
Pages 1-11
-
-
- Jessica J. Kraeft, Susanna I. Lee
Pages 25-41
-
- Robert A. Soslow, Esther Oliva
Pages 47-81
-
- Jose Palacios, Paola Dal Cin
Pages 85-103
-
- Patricia M. Baker, Esther Oliva
Pages 107-146
-
-
- Yukio Sonoda, George Monemvasitis
Pages 171-181
-
- Onyinye Balogun, Stella Lymberis, Peter B. Schiff
Pages 183-199
-
- Laura M. Divine, Matthew A. Powell
Pages 201-221
-
-
- Marcela G. del Carmen, Neil S. Horowitz
Pages 235-246
-
-
- Jonathan D. Black, Dana M. Roque, Leslie I. Gold, Alessandro D. Santin
Pages 259-271
-
- Jose Palacios, Paola Dal Cin
Pages 105-105
-
- Patricia M. Baker, Esther Oliva
Pages 147-149
-
- Jessica J. Kraeft, Susanna I. Lee
Pages 43-45
-
- Robert A. Soslow, Esther Oliva
Pages 83-84
-
Back Matter
Pages 273-278
About this book
There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009. A book focusing on these cancers was timely, with emergent sophistication in diagnosis increasingly impacting clinical decision-making. However, five years later, the need for an updated book on this topic is even stronger as oncologists recognize opportunities to impact the outcome on women that are increasingly diagnosed with these malignancies. Uterine Cancer: Screening, Diagnosis, and Treatment, Second Edition, part of the Current Clinical Oncology series, enhances the awareness on this somewhat neglected area of therapeutics, helping to integrate targeted therapies into the management of women with uterine cancer. Written by experts in the field in a highly practical and comprehensive manner, it is a must-have for all gynecological residents and fellows, as well as gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors who wish to provide their patients with the best possible care.
Editors and Affiliations
-
NYU Langone Medical Center, New York, USA
Franco Muggia
-
Division of Gynecologic Oncology, Yale University, Yale School of Medicine, New Haven, USA
Alessandro D. Santin
-
Department of Pathology, Massachusetts General Hospital, Boston, USA
Esther Oliva
-
Harvard Medical School, Boston, USA
Esther Oliva
About the editors
Dr. Franco Muggia is a Professor in the Department of Medicine at the Perlmutter Cancer Center at NYU Langone. His medical expertise include gynecologic cancers, breast cancer, and gynecologic oncology. Dr. Alessandro Santin is a Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. He is also the Clinical Research Program Leader in the Gynecologic Oncology Program at Yale Cancer Center. Dr. Esther Oliva is a Pathologist at Massachusetts General Hospital and a Professor of Pathology at Harvard Medical School.
